DK0452697T3 - Stabilisator til et 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamid-holdigt præparat og stabiliseringsfremgangsmåde derfor - Google Patents

Stabilisator til et 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamid-holdigt præparat og stabiliseringsfremgangsmåde derfor

Info

Publication number
DK0452697T3
DK0452697T3 DK91104502.9T DK91104502T DK0452697T3 DK 0452697 T3 DK0452697 T3 DK 0452697T3 DK 91104502 T DK91104502 T DK 91104502T DK 0452697 T3 DK0452697 T3 DK 0452697T3
Authority
DK
Denmark
Prior art keywords
hexenamide
hydroxyimino
nitro
stabilizer
ethyl
Prior art date
Application number
DK91104502.9T
Other languages
English (en)
Inventor
Yoshio Ueda
Norio Onishi
Mitsuru Yasumura
Kazuto Okimoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0452697T3 publication Critical patent/DK0452697T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK91104502.9T 1990-03-28 1991-03-22 Stabilisator til et 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamid-holdigt præparat og stabiliseringsfremgangsmåde derfor DK0452697T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8179090 1990-03-28
JP21305190 1990-08-10

Publications (1)

Publication Number Publication Date
DK0452697T3 true DK0452697T3 (da) 1996-01-02

Family

ID=26422796

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91104502.9T DK0452697T3 (da) 1990-03-28 1991-03-22 Stabilisator til et 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamid-holdigt præparat og stabiliseringsfremgangsmåde derfor

Country Status (15)

Country Link
EP (1) EP0452697B1 (da)
JP (1) JPH0678227B2 (da)
CN (1) CN1055355A (da)
AT (1) ATE131044T1 (da)
AU (1) AU642988B2 (da)
CA (1) CA2038716A1 (da)
DE (1) DE69115102T2 (da)
DK (1) DK0452697T3 (da)
ES (1) ES2080175T3 (da)
GR (1) GR3018419T3 (da)
HU (1) HU210641B (da)
IE (1) IE71022B1 (da)
IL (1) IL97648A (da)
PT (1) PT97164B (da)
RU (1) RU2023449C1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5270014A (en) * 1975-12-05 1977-06-10 Senju Pharma Co Stabilization of pyrido*3*22a*phenoxadine compounds
ZA838831B (en) * 1982-12-31 1984-07-25 Fujisawa Pharmaceutical Co New nitro aliphatic compounds,process for preparation thereof and use thereof

Also Published As

Publication number Publication date
CN1055355A (zh) 1991-10-16
IL97648A0 (en) 1992-06-21
PT97164A (pt) 1992-01-31
DE69115102T2 (de) 1996-05-15
GR3018419T3 (en) 1996-03-31
AU642988B2 (en) 1993-11-04
EP0452697B1 (en) 1995-12-06
IE71022B1 (en) 1997-01-15
HUT56488A (en) 1991-09-30
AU7381591A (en) 1991-10-03
IE910986A1 (en) 1991-10-09
CA2038716A1 (en) 1991-09-29
ATE131044T1 (de) 1995-12-15
JPH0678227B2 (ja) 1994-10-05
PT97164B (pt) 1998-07-31
RU2023449C1 (ru) 1994-11-30
EP0452697A1 (en) 1991-10-23
IL97648A (en) 1995-12-08
JPH04217915A (ja) 1992-08-07
HU210641B (en) 1995-06-28
ES2080175T3 (es) 1996-02-01
DE69115102D1 (de) 1996-01-18

Similar Documents

Publication Publication Date Title
DK0495982T3 (da) Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
DK551989D0 (da) 3-piperidinyl-1,2-benzisoxazoler, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
FI901421A0 (fi) N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat.
HUT75031A (en) Azolylamine derivatives and pharmaceutical compositions of antifungal effect
DK0644199T3 (da) Cykliske antimikrobielle peptider og fremstilling deraf
FI941723A (fi) Lipofiilisen oligosakkaridin antibiootin suolaa sisältävät seokset
NO913087L (no) Ny tricyklisk forbindelse eller salter derav, fremgangsmaate for fremstilling derav og antimikrobielt middel inneholdende slike.
FI924285A (fi) 4-desoxi-4-epipodophyllotoxinderivat eller ett farmaceutiskt acceptabelt salt daerav
FI893701A (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
DK0452697T3 (da) Stabilisator til et 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamid-holdigt præparat og stabiliseringsfremgangsmåde derfor
IL169577A0 (en) Oligosaccharide derivatives and pharmaceutical compostions containing the same
NO923983L (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
ATE493988T1 (de) Pyrimidinderivate enthaltendes medikament